MADRIGAL PHARMACEUTICALS, INC. MDGL

Latest FY: 2025 Healthcare Biotechnology
Market Price $542.22
Market Cap $12.50B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑432.1% YoY
$958.40M
Full year reported
Net Income ↑38.1% YoY
-$288.28M
Net Margin: -30.1%
Free Cash Flow ↑58.4% YoY
-$190.02M
FCF Yield: -1.52%
EPS (Diluted) ↑41.3% YoY
$-12.85
Basic: $-12.85
Return on Equity Efficiency
-47.8%
ROA: -22.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (MDGL)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $0.0M $-15.9M $-26.4M $-5.07 0.00% $-17.6M $-17.6M
FY 2017 $0.6M +1,055.2% $-24.4M $-31.2M -18.1% $-2.54 +49.9% 0.00% $-22.3M $-22.4M -27.4%
FY 2018 $7.7M +1,274.7% $-25.4M $-32.8M -5.3% $-2.22 +12.6% 0.00% $-25.5M $-25.5M -13.8%
FY 2019 -100.0% $-72.3M $-83.9M -155.9% $-5.45 -145.5% 0.00% $-41.6M $-41.8M -63.7%
FY 2020 $-184.8M $-202.2M -140.9% $-13.09 -140.2% 0.00% $-157.6M $-157.9M -277.8%
FY 2021 $-205.2M $-241.8M -19.6% $-14.63 -11.8% 0.00% $-183.9M $-184.1M -16.6%
FY 2022 $-295.4M -22.1% $-17.23 -17.8% 0.00% $-224.9M $-225.1M -22.2%
FY 2023 $-373.6M -26.5% $-19.99 -16.0% 0.00% $-324.2M $-325.7M -44.7%
FY 2024 $180.1M $165.5M $-465.9M -24.7% $-21.90 -9.6% 0.00% $-455.6M $-457.0M -40.3%
FY 2025 $958.4M +432.1% $513.7M $-288.3M +38.1% $-12.85 +41.3% 0.00% $-189.6M $-190.0M +58.4%
$

Valuation

Market Price $542.22
Market Cap $12.50B
Enterprise Value $12.64B
P/E Ratio N/A
P/B Ratio 20.74
FCF Yield -1.52%
Dividend Yield N/A
Shares Outstanding 23,055,700
%

Profitability & Margins

Gross Margin 53.60%
Operating Margin -31.31%
Net Margin -30.08%
Return on Equity (ROE) -47.83%
Return on Assets (ROA) -22.89%
Asset Turnover 0.76x
Revenue 3-Yr CAGR N/A
🛡️

Financial Health & Liquidity

Current Ratio 4.01
Cash Ratio 0.64
Debt / Equity 0.564
Debt / Assets 0.270
Cash & Equivalents $198.69M
Total Debt $339.88M
Book Value / Share $26.14
💧

Cash Flow Efficiency

Operating Cash Flow -$189.55M
Capital Expenditures (CapEx) $467.00K
Free Cash Flow -$190.02M
OCF / Revenue -19.78%
FCF / Revenue -19.83%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-12.85
EPS (Basic) $-12.85
Dividends / Share N/A
Book Value / Share $26.14
EPS YoY Growth 41.32%
🏛️

Balance Sheet (FY 2025)

Total Assets $1.26B
Total Liabilities $656.90M
Stockholders' Equity $602.69M
Current Assets $1.25B
Current Liabilities $310.29M